Home
Conditions
Chronic Myelomonocytic Leukemia

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

194 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

Ascorbic Acid Levels in MDS, AML, and CMML Patients

NCT03526666

Conditions: AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
Locations: Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States

Metro Health - University of Michigan Health Wyoming, Michigan, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01305200

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
Locations: Children's Oncology Group Arcadia, California, United States

City of Hope Duarte, California, United States

Children's Hospital and Research Center at Oakland Oakland, California, United States

Rady Children's Hospital - San Diego San Diego, California, United States

View all 35 locations

View Trial Details

Completed

WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT02666950

Conditions: Bone Marrow Diseases, Chromosome 5q Deletion Syndrome, Chronic Disease, +18 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT01165996

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes

NCT03363399

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +12 more
Locations: Centre Hospitalier Universitaire Estaing Clermont-Ferrand, France

Centre Hospitalier Universitaire Grenoble Alpes Grenoble, France

View Trial Details

Completed

Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

NCT00451048

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

London Regional Cancer Program London, Ontario, Canada

Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

NCT01789255

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +176 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details

Completed

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

NCT01484015

Conditions: Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia trial results

Related conditions